Vaccine Development

The CDC suggests the HPV vaccine for all guys ages 11 to 12 and those to age 21 who have not had each of the three measurements of the immunization. It is additionally prescribed for gay, swinger, and men who have intercourse with men. Men through age 26 who are immunocompromised, including HIV positive, who have not had every one of the three dosages may likewise profit. The vaccine is best when given to more youthful guys. The vaccine has been demonstrated to forestall genital warts and anal cancers in guys and may counteract diseases of the oropharynx and penis (ACIP, 2014).

  • Classes of drugs and mechanism
  • Immunology and strategies towards HIV and retroviral infections
  • HIV/AIDS and STDs/STIs: Vaccines research and development
  • Nucleoside analogues and molecular mechanisms
  • HIV: Current pharmaceutical design

Related Conference of Vaccine Development

September 01-02, 2017

4th International Conference on Parasitology

Prague, Czech Republic
November 2-3, 2017

9th World Congress and Expo on Immunology

Atlanta, Georgia, USA
November 02-03, 2017

9th World Congress on Immunity, Inflammation and Immunotherapies

Atlanta, Georgia, USA
November 06-07, 2017

2nd International Conference on Autoimmunity

Frankfurt, Germany
November 08-09, 2017

3rd Antibodies and Bio Therapeutics Congress & B2B

Las Vegas, Nevada, USA
November 13-14, 2017

5th International Conference on HIV/AIDS, STDs and STIs

Las Vegas, Nevada, USA
Dec 14-15, 2017

World Immunology Congress

Dubai, UAE

9th European Immunology Conference

June 14-16, 2018 Rome, Italy

Vaccine Development Conference Speakers

Recommended Sessions

Related Journals

Are you interested in